Sign in

You're signed outSign in or to get full access.

John Gallagher

Senior Vice President and Chief Financial Officer at CertaraCertara
Executive

About John Gallagher

John E. Gallagher III (age 52) is Certara’s Senior Vice President and Chief Financial Officer, a role he has held since April 2023; prior roles include CFO of Cue Health and senior finance leadership positions at Becton Dickinson, NBCUniversal, GE and Ford . Under his tenure, 2024 revenue reached $385.1 million (+9% YoY) and Adjusted EBITDA was $122.0 million; the company emphasizes EBITDA margin in its pay programs and guided to low-30s adjusted EBITDA margin in 2025 commentary . Since 12/31/2020, Certara’s TSR translated an initial $100 investment to $27.97 by year-end 2024, and the company introduced a $100 million repurchase authorization (with $25 million executed in Q2 2025), while prioritizing R&D and new software launches including AI-enabled Certara IQ and cloud Phoenix .

Past Roles

OrganizationRoleYearsStrategic impact
Cue Health (NASDAQ: HLTH)Chief Financial OfficerMar 2021 – Mar 2023Public-company CFO; led finance through post-COVID transition .
Becton, Dickinson & Co. (BD)SVP, CFO Medical Segment and TreasurerJul 2018 – Feb 2021Segment CFO; enterprise treasury leadership .
BDSVP, Controller & Chief Accounting OfficerDec 2014 – Jul 2018Led corporate controllership and accounting .
BDCorporate Treasurer2012 – 2018Responsible for corporate finance and FP&A .
NBCUniversalVP, Financial Planning & AnalysisOct 2009 – Sep 2012Led FP&A for diversified media portfolio .
General ElectricAssistant Controller, Corporate TreasuryOct 2006 – Oct 2009Treasury accounting leadership .
Ford Motor CompanyVarious roles (Treasury, Internal Audit, Product Dev.)Early careerRotational finance and audit experience .

Fixed Compensation

YearBase Salary ($)Target Bonus (%)Target Bonus ($)Actual Bonus Paid ($)Notes
2024592,249 50% 296,125 219,132 (74% multiplier) AIB metrics: 80% Adj. EBITDA, 20% revenue; blended corporate/business unit construct for CFO .
2023431,250 50% (unchanged vs 2023) N/A184,000 (AIB) Also received $435,750 in “Bonus ($)” (includes transition/other items); A&R agreement reimbursed $235,750 for unpaid bonus from prior employer with recoup if recovered .

Performance Compensation

Annual Incentive (AIB Plan) – 2024 Design and Payout

  • Metrics and weighting: Adjusted EBITDA (80%) and Revenue (20%), applied to corporate and divisional scorecards; CFO multiplier uses 20% company-wide + 80% blended division rate .
  • Threshold: If company-wide adjusted EBITDA <90% of target, no payout (met in 2024) .
  • 2024 Payout for Gallagher: 74% multiplier on $296,125 target = $219,132 .
MetricWeightingTargetActualPayout/MultiplierVesting/Timing
Adjusted EBITDA80% Not disclosed>90% of target achieved (threshold crossed) Included in 74% overall multiplier Paid in cash in 2025 for FY2024 .
Revenue20% Not disclosedAchievement above threshold (by unit) Included in 74% overall multiplier Paid in cash in 2025 for FY2024 .

Long-Term Incentives (LTI)

  • Vehicle mix: 40% time-based RSUs; 60% PSUs (3-year performance) .
  • 2024 grant (Apr 1, 2024): RSUs 45,571; Target PSUs 68,357; grant-date fair value $2,123,846 .
  • PSU metrics and gates: Annual revenue (Tranche I) and adjusted EBITDA (Tranche II) over FY2024-2026; linear scale (50%-200%); forfeit if average EBITDA margin <20% over first two years; rTSR modifier ±20% vs peer group .
  • 2023 outstanding: Target PSUs 56,848; RSUs 37,898 (3-year vest) and 29,326 (2-year) .
GrantInstrumentQuantityKey TermsStatus
2024 LTI (Apr 1, 2024)RSUs45,571 Vests 1/3 on Apr 1 of 2025, 2026, 2027 1/3 vested 4/1/2025 .
2024 LTI (Apr 1, 2024)PSUs (target)68,357 3-year performance (2024–2026); revenue and adj. EBITDA tranches; rTSR modifier; margin gate Outstanding.
2023 LTI (Apr 1, 2023)RSUs29,326 Two-year vesting; half vested 4/1/2024, completes 4/1/2025 In-progress.
2023 LTI (Apr 1, 2023)RSUs37,898 Vests 1/3 on Apr 1 of 2024, 2025, 2026 In-progress.
2023 LTI (Apr 1, 2023)PSUs (target)56,848 3-year performance (2023–2025); earned/distributed after period Outstanding.

Equity Ownership & Alignment

ItemDetail
Total beneficial ownership60,704 shares; <1% of outstanding as of Mar 28, 2025 .
Unvested RSUs (12/31/2024)85,500 units; market value $910,575 at $10.65/share .
Target PSUs outstanding (12/31/2024)125,205 units; market/payout value $1,333,433 at $10.65/share (performance/payout contingent) .
Next vesting dates/sizesRSUs: 1/3 of 2024 grant vested 4/1/2025; remaining 2/3 vest 4/1/2026 and 4/1/2027; 2023 RSUs vest 4/1/2025 and 4/1/2026 per schedules .
Ownership guidelinesExecutives must hold 2x base salary; assessed annually on Feb 1 .
Compliance statusAs of Feb 1, 2025, all NEOs met minimum equity ownership thresholds (allowing for initial compliance period) .
Hedging/pledgingHedging prohibited; pledging requires pre-clearance from General Counsel .
Options outstandingNone disclosed for executives; company is not currently granting options .

Employment Terms

  • Start date and role: Appointed SVP & CFO effective April 1, 2023 .
  • Initial compensation on hire: Base salary $575,000; target bonus 50% of base; sign-on equity value $2.75 million (PSUs $1.26m; RSUs $0.84m vesting over 3 years; RSUs $0.65m vesting over 2 years) .
  • Amended and Restated Employment Agreement (Nov 7, 2023): Company paid $235,750 for unpaid prior-employer bonus (reimbursable to Certara upon recovery) and agreed to reimburse legal fees related to that claim .
  • Severance (no cause/good reason, no CIC): Six months’ base salary continuation; payment of full annual target bonus amount for current year; accrued obligations .
  • Change-in-control (double-trigger): Six months’ base salary; full annual target bonus for current year; accelerated vesting value for unvested RSUs ($910,575 at 12/31/2024); estimated value for PSUs ($873,826; subject to performance determination) .
  • Restrictive covenants: Perpetual confidentiality and non-disparagement; IP assignment; non-compete during employment and for one year thereafter; non-solicit of employees/customers during employment and for one year thereafter .
  • Clawback: Company-adopted Dodd-Frank compliant clawback in 2023 covering incentive compensation tied to financial reporting measures .

Performance & Track Record

IndicatorDetail
Revenue growth (FY2024)$385.1 million, +9% YoY vs. $354.3 million in 2023 .
Adjusted EBITDA (FY2024)$122.0 million (company-selected measure for pay-versus-performance) .
TSR context$100 invested on 12/31/2020 worth $27.97 on 12/31/2024 (S&P Small Cap 600 Healthcare peer TSR $82.64 over same window) .
Strategy and capital allocation (CFO commentary)Prioritizing R&D and new software (Certara IQ, cloud Phoenix, Pinnacle 21 Enterprise); $100m buyback authorization with $25m executed in Q2 2025; continued M&A screening with software tilt .

Compensation Structure Analysis

  • Mix and leverage: High share of at-risk pay via AIB and PSUs aligns realized pay with revenue/EBITDA and relative TSR; AIB weighted 80% to Adjusted EBITDA encourages profitability discipline; revenue receives 20% weighting .
  • Metric calibration and rigor: 2024 AIB required ≥90% of Adjusted EBITDA target to fund; 2024 multiplier for CFO was 74%, below target, indicating formulaic restraint; no discretionary upward adjustments were made to AIB outcomes .
  • Equity design: 3-year PSUs with EBITDA and revenue tranches, 20% EBITDA margin gate and rTSR modifier strengthen pay-for-performance; time-based RSUs provide retention continuity .
  • Governance safeguards: No excise tax gross-ups; robust clawback; hedging prohibited; pledging requires pre-clearance; stock ownership guidelines enforced, with NEOs in compliance as of 2/1/2025 .
  • Shareholder sentiment: 2024 Say-on-Pay passed with 94.8% approval, supporting the program design .

Risk Indicators & Insider Selling Pressure

  • Scheduled vesting cadence: Significant RSU tranches vest around April 1 each year (e.g., 2024 and 2023 grants), potentially creating periodic selling windows and supply; 2024 RSUs vest 4/1/2025–2027; 2023 RSUs vest through 4/1/2026 .
  • Pledging/hedging: Policy restricts pledging (pre-clearance) and prohibits hedging, reducing misalignment risks; no individual pledging by Gallagher disclosed .
  • Change-in-control economics: Double-trigger treatment with cash severance equal to 6 months salary plus full-year target bonus and equity acceleration provides retention but limits windfalls relative to CEO terms; estimated RSU and PSU values detailed in proxy .
  • No option repricing/red flags: Company noted it is not granting options currently and does not disclose option repricing; no tax gross-ups; presence of clawback .

Equity Detail and Vesting Schedules

AwardGrant dateQuantityVesting scheduleNotes
RSUsApr 1, 202445,571 1/3 on 4/1/2025; 1/3 on 4/1/2026; 1/3 on 4/1/2027 Time-based retention.
PSUs (target)Apr 1, 202468,357 3-year performance (2024–2026); payout in early 2027 Rev/Adj. EBITDA tranches; rTSR modifier; 20% margin gate .
RSUsApr 1, 202329,326 50% on 4/1/2024; 50% on 4/1/2025 Two-year vest.
RSUsApr 1, 202337,898 1/3 on 4/1/2024; 1/3 on 4/1/2025; 1/3 on 4/1/2026 Three-year vest.
PSUs (target)Apr 1, 202356,848 3-year performance (2023–2025); payout after final determination Outstanding.

Employment Contracts, Severance, and Change of Control

TermWithout Cause / Good ReasonChange in Control (Double-Trigger)
Cash severance6 months base salary 6 months base salary .
Bonus treatmentFull annual target bonus for current year (pro rata deemed 100%) Full annual target bonus for current year .
Equity treatmentSee plan and award terms; no automatic RSU vesting absent CIC RSUs accelerate (Gallagher est. $910,575 at 12/31/2024); PSUs per performance determination (Gallagher est. $873,826) .
Restrictive covenantsConfidentiality, non-disparagement, IP assignment, 1-year non-compete and non-solicit Same as left.
ClawbackDodd-Frank compliant, adopted 2023 Applicable.

Investment Implications

  • Alignment and discipline: High at-risk mix, rigorous AIB guardrails (90% EBITDA threshold) and multi-year PSUs with rTSR and margin gate support pay-performance alignment and capital discipline .
  • Retention vs. liquidity events: Meaningful RSU vests each April could create episodic supply; however, ownership guidelines and anti-hedging reduce misalignment; no pledging disclosed .
  • Execution focus: CFO’s strategy emphasizes accelerating organic software growth via R&D and product launches (Certara IQ, cloud Phoenix), with balanced capital allocation (M&A screening, new $100m buyback; $25m executed), which can support LT growth and per-share metrics if sustained .
  • Risk checks: No excise tax gross-ups, robust clawback, and no option repricing reduce governance risk; say-on-pay support (94.8% in 2024) indicates shareholder acceptance of program structure .